Regulatory NK cells in autoimmune disease

NK cells are defined as the major components of the immunological network which exerts defense against tumors and viral infections as well as regulation of innate and adaptive immunity, shaped through interaction with other cells like T cells. According to the surface markers, NK cells can be divided into CD56dim NK and CD56bright NK subsets. CD56bright NK cells usually are known as regulatory NK cells. Once the immune system loses its self-tolerance, autoimmune diseases develop. NK cells and their subsets can be altered during autoimmune diseases, indicative of their prominent regulatory roles and even pathological and protective functions in autoimmune disorders. In this regard, activation of CD56bright NK cells can suppress activated autologous CD4+ T cells and subsequently prevent the initiation of autoimmunity. In this review article, we summarize the roles of regulatory NK cells in autoimmune disease occurrence which needs more research to uncover their exact related mechanism. It seems that targeting NK cells can be a promising therapeutic platform against autoimmune diseases.

Automated summary

NK cells play a vital role in defending against tumors and viral infections and regulating innate and adaptive immunity. They can be divided into CD56dim NK and CD56bright NK subsets, with CD56bright NK cells known as regulatory NK cells. Their activation can suppress autologous CD4+ T cells and prevent the initiation of autoimmunity. This review summarizes the roles of regulatory NK cells in autoimmune diseases and suggests targeting NK cells as a promising therapeutic approach.